vimarsana.com
Home
Live Updates
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023 : vimarsana.com
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
Extended funding of operations into 2027 by prioritizing investment in core clinical candidates and research platform value drivers as well as de-...
Related Keywords
Washington
,
United States
,
South San Francisco
,
California
,
Seattle
,
Fred Hutch
,
Lynn Seely
,
Ellen Rose
,
Tina Albertson
,
Nasdaq
,
Exchange Commission
,
Development Expenses
,
Lyell Immunopharma Inc
,
Fred Hutchinson Cancer Center
,
Chief Medical Officer
,
Quarter Updates
,
Recent Business
,
Chimeric Antigen Receptor
,
Cellare Cell Shuttle
,
Annual Meeting
,
San Diego
,
Lyell Immunopharma
,
Private Securities Litigation Reform Act
,
Annual Report
,
Quarterly Report
,
Operations Data
,
Months Ended September
,
Condensed Consolidated Statements
,
Sheet Data
,
Vice President
,
vimarsana.com © 2020. All Rights Reserved.